<rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:digibug.ugr.es:10481/100736">
      <dc:title>Caution with the use of dexamethasone in patients with COVID-19 in its initial phases</dc:title>
      <dc:creator>Callejas Rubio, José Luis</dc:creator>
      <dc:creator>Aomar Millán, I.</dc:creator>
      <dc:creator>Moreno Higueras, M.</dc:creator>
      <dc:creator>Martín Ripoll, L.</dc:creator>
      <dc:creator>Yuste Osorio, E.</dc:creator>
      <dc:creator>Rios Fernández, Raquel</dc:creator>
      <dc:date>2025-01-28T11:21:59Z</dc:date>
      <dc:date>2025-01-28T11:21:59Z</dc:date>
      <dc:date>2021-12</dc:date>
      <dc:type>journal article</dc:type>
      <dc:identifier>Callejas Rubio JL, Aomar Millan I, Moreno-Higueras M, Martín Ripoll L, Yuste Osorio E, Ríos-Fernández R. Caution with the use of dexamethasone in patients with COVID-19 in its initial phases. Rev Clin Esp (Barc). 2021 Dec;221(10):592-595. doi: 10.1016/j.rceng.2021.02.005. Epub 2021 Sep 17. (IF: 1.3; Q3)</dc:identifier>
      <dc:identifier>https://hdl.handle.net/10481/100736</dc:identifier>
      <dc:identifier>10.1016/j.rceng.2021.02.005</dc:identifier>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:rights>open access</dc:rights>
      <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
      <dc:publisher>Rev Clin Esp</dc:publisher>
   </ow:Publication>
</rdf:RDF>